Serving the Miami-Fort Lauderdale-Pompano Beach metro area
34 of 144 GLP-1 clinics in Miami prescribe semaglutide (24% of local providers). Compare pricing, insurance acceptance, and patient reviews to find the right provider.
Miami has a population of 442,241 in the Miami-Fort Lauderdale-Pompano Beach metro area. With a local obesity rate of 27.3%, demand for GLP-1 medications like semaglutide continues to grow. The city is well-served with 34 providers currently prescribing semaglutide.
Medicaid coverage: Florida Medicaid does not currently cover GLP-1 weight loss medications. Patients without commercial insurance coverage may want to explore compounded options or manufacturer savings programs.
Telehealth in Florida: Florida allows telehealth prescribing by Florida-licensed providers. The Florida Board of Medicine requires a patient-provider relationship established via video or in-person visit before prescribing. 8 semaglutide providers in Miami offer telehealth consultations.
There are 34 clinics in Miami, Florida that prescribe Semaglutide (Ozempic/Wegovy) out of 144 total GLP-1 clinics in the area. 19 of these clinics accept insurance.
Semaglutide (Ozempic/Wegovy) programs in Miami typically cost between $499 and $999 per month. Prices depend on dosage, whether you use branded or compounded versions, and your insurance coverage.
Yes. 8 semaglutide providers serving Miami offer telehealth consultations. Florida allows telehealth prescribing by Florida-licensed providers. The Florida Board of Medicine requires a patient-provider relationship established via video or in-person visit before prescribing. You can complete your consultation via video call and have medication shipped to your home.
Learn about Semaglutide (Ozempic/Wegovy) – dosing, side effects, costs, and FDA approval status.
This site is for educational purposes only and is not medical advice. Always consult a healthcare provider before starting any medication. Full disclaimer
No. Florida Medicaid does not currently cover GLP-1 weight loss medications. Patients without commercial insurance coverage may want to explore compounded versions or manufacturer savings programs to reduce costs.
Yes. Ozempic and Wegovy (brand names for semaglutide) are FDA-approved for weight management. Your provider will determine the right dosage based on your health history and goals.
GLP-1 Medications
Compare Ozempic, Wegovy, Mounjaro, and more
